Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 604 | nsp12:T604S; | CL-3d; |
| 643 | nsp12:T643-; | CL-3e; |
| 643 | nsp12:T643A; | CL-3c;CL-3e; |
| 680 | nsp12:T680-; | CL-3d; |
| 701 | nsp12:T701-; | CL-5; |
| 739 | nsp12:T739-; | CL-3b;CL-3c;CL-3e; |
| 739 | nsp12:T739A; | CL-3d; |
| 769 | nsp12:T769I; | CL-3e; |
| 801 | nsp12:T801N; | CL-3d; |
| 803 | nsp12:T803-; | CL-3b;CL-3e;CL-5; |
| 803 | nsp12:T803A; | CL-3b; |
| 803 | nsp12:T803N; | CL-3c; |
| 803 | nsp12:T803S; | CL-1b;CL-3e; |
| 806 | nsp12:T806-; | CL-3b;CL-3c;CL-3e;CL-3f; |
| 806 | nsp12:T806A; | CL-3e; |
| 806 | nsp12:T806N; | CL-1a_3d; |
| 817 | nsp12:T817-; | CL-3d; |
| 850 | nsp12:T850A; | CL-3b; |
| 850 | nsp12:T850I; | CL-3d;CL-3e; |
| 853 | nsp12:T853-; | CL-1b; |
| 870 | nsp12:T870-; | CL-3e;CL-3f; |
| 870 | nsp12:T870A; | CL-3f; |
| 896 | nsp12:T896I; | CL-3d; |
| 908 | nsp12:T908-; | CL-2;CL-3b; |
| 908 | nsp12:T908N; | CL-1a_3e;CL-3d; |
| 912 | nsp12:T912N; | CL-3c; |
| 926 | nsp12:T926-; | CL-3e; |
| 926 | nsp12:T926A; | CL-3b;CL-3d; |
| 929 | nsp12:T929I; | CL-3d; |
| 111 | nsp12:V111-; | CL-3f; |
| 111 | nsp12:V111I; | CL-3c;CL-3d; |
| 11 | nsp12:V11A; | CL-3b;CL-3e; |
| 11 | nsp12:V11I; | CL-3b;CL-3e;CL-3f; |
| 128 | nsp12:V128I; | CL-3d;CL-3e; |
| 147 | nsp12:V147A; | CL-3b; |
| 147 | nsp12:V147I; | CL-3e;CL-5; |
| 166 | nsp12:V166-; | CL-3b; |
| 174 | nsp12:V174-; | CL-3c;CL-3d;CL-3e; |
| 182 | nsp12:V182-; | CL-3e; |
| 182 | nsp12:V182L; | CL-2;CL-3d; |
| 190 | nsp12:V190I; | CL-3d;CL-3e; |
| 202 | nsp12:V202I; | CL-3e; |
| 204 | nsp12:V204I; | CL-1a_3e;CL-3d; |
| 231 | nsp12:V231I; | CL-3b;CL-3f;CL-4; |
| 233 | nsp12:V233A; | CL-3c; |
| 234 | nsp12:V234-; | CL-3e; |
| 234 | nsp12:V234A; | CL-1b; |
| 257 | nsp12:V257-; | CL-3e; |
| 257 | nsp12:V257I; | CL-3b; |
| 299 | nsp12:V299-; | CL-3e;CL-3f; |
Page 171 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com